[The Update and the Future of Antiangiogentic Agents]

MeSH terms

• Angiogenesis Inhibitors / adverse effects
• Angiogenesis Inhibitors / therapeutic use*
• Bevacizumab / adverse effects
• Bevacizumab / therapeutic use*
• Clinical Trials as Topic
• Female
• Humans
• Neoplasm Staging
• Ovarian Neoplasms / drug therapy*
• Ovarian Neoplasms / pathology
• Recurrence